{"name":"Urica Therapeutics Inc.","slug":"urica-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"dontinurad","genericName":"dontinurad","slug":"dontinurad","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"dontinurad","genericName":"dontinurad","slug":"dontinurad","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQQUtjdVNtNkdHNVZaYTlRYnhTMG9pX3ZKYXY4R2Y4UDh3RG5NZ2lBQURZdEE4R2pSSUhBaUc5VXEyVFBBMmJYS3ZkNEZodkFQWmZ0SG1NcWNzakd4NHdwWFBseWJVYkc3SWxJTzRjcjhiNFJqdTc0WnQyckxCOFlQdUgtUkJsck4yeXpSQms0cWk2QlJPaE4tRWdibDBrbFVRQ0FnekxIbU1tUzI4TDBrSTlrQ2JVWlFKdjNCTlNCRQ?oc=5","date":"2026-04-03","type":"trial","source":"Clinical Leader","summary":"With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout - Clinical Leader","headline":"With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQN01tV05keG1mNFhwd2tITi1EM2s5T1VYakJNb2hUNTJ1SU9hWlUyLUszWVh1a093QlJOMkt4RGRfY0Z2LXBuUGlJV05qMXc2UUFFbENhcldiaUJjN0Y0N0xZbDhQZlZXTFlQODlfNmxNdGxfU1JDcXVYT0QzR3ppODFtNXI1UUhaWDlvRUNUV2xkUjU3Q2k5UUFpVXYwRFNXME0wVFlvbUc1dllHU1V1eHl2cThkYnk0VzNIamVubTBzenA0ZmlBTnlRaw?oc=5","date":"2026-03-31","type":"pipeline","source":"Sahm","summary":"Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights - Sahm","headline":"Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPREl6YVVmSFVjRHBaWl9FTmU3M0UyT1F2Wk5iczJUTHZkYTgtRnNQajNzSTNsTEEzYmFYNHc3alNDOXc4NFZTcVdKSUVlRWVPSGNjcjVDa0xsaU5kZVdfeXhET2RCcERkUXNPYlh5SWctTUVCZjl6b2M0cGpkbGVCWWF3UnpCcklZOTkwVWVHYXlQMzZJN0xj?oc=5","date":"2025-10-21","type":"trial","source":"Yahoo Finance","summary":"Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout - Yahoo Finance","headline":"Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBVdG8xU0VMZVFNM0MwaEJFdnFqMzU2Y09FdjFSVHA5RnZRUVpobHhhVERmMVg3SGVLa0NEbnRJU29qVXVWMVJLUHZjTVU3ZHJ2MWRGbkVQUm12dlBpRkE5LURpcXU?oc=5","date":"2025-10-02","type":"pipeline","source":"The Pharma Letter","summary":"Crystalys Therapeutics - The Pharma Letter","headline":"Crystalys Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQSGUtdW5EMkJRNXowZFBOLS1SdDJnVFoyM2huOVllZlBDMi1VQkFUZktra0Y3enJldUs5Y0ZTTXVrVG90SnoxcmwySDJnQnJKZFZvVm9EZVU3c3c2RnI2azh5eU9QOGdCM1dFNHRsNXN3czltVU44UzVHMlUwZF8wQWFCUjZJU1JneUUzUENwd2VHaTJ6WTlF?oc=5","date":"2025-10-01","type":"pipeline","source":"Yahoo Finance","summary":"Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing - Yahoo Finance","headline":"Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOY2xBdjBXZkJBX2FwaFk0NFktRlFndktXdkQxUDc4SHBqRTZ1MnZVejdSZFpRLU5oc0ZUWDNoMG5WTVplM0NKR2FucGVzeUpfMnpvUUVnMHRRSGpjbTNmY19zTEZncl9TYkpyTndqNjBCajBhTW5rOFNpakdGODlHQ05n?oc=5","date":"2025-10-01","type":"pipeline","source":"pharmaphorum","summary":"Crystalys emerges with $205m, and other biofinancings - pharmaphorum","headline":"Crystalys emerges with $205m, and other biofinancings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNalMwQkNibUNDcVZFZGNqYm5oWUhjWHc1UnNaTTlJY1ludnJueVVCdl9VVlhIZTZLcER0bDI3RmVLbWl6TEFwUnZrbm96MWVSajhnX0t4VTVIRjliblQ2U1VYODB6UEZybUo2T2ttYnNrVXcwLTAzYTY0OFVBN1p4ZHFOdDgzS1d0b1YteGxpSUZURDVsM3RYN1BHV0pZcnlvN0s4THZxZmx6aE1yVzNDMVd6Q0NnVDRGcGxUR0MwMzg0OW13Nm5BVW5WWkJaTjhveExHTFQxQmVUNDZnRl9WcXoxa0Y3UQ?oc=5","date":"2025-09-30","type":"trial","source":"reuters.com","summary":"Crystalys Therapeutics launches with $205 million funding round for trials of gout drug - reuters.com","headline":"Crystalys Therapeutics launches with $205 million funding round for trials of gout drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPWHFSTklrY25mZU5vaEVuTnMwYW1scXYtZk9TUlg1aWcxT19BUXByVjhOMWNpME5ITnY5Nmp1Q2psS2p1ZGRFRldhYmJWbmhTSzVuNWxlcHNOMlVTeVJMSGlvc1NaQUN2ODg1aUMzNnRJNk80MFRXRkhVeE5YYURxdnllMDJzZkF1bXRQcXJYcVgwTWdyVTdHQWlCbklxMXlRcFFqdjJNajJrX2Jl?oc=5","date":"2025-09-30","type":"trial","source":"Endpoints News","summary":"Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europe - Endpoints News","headline":"Crystalys lands $205M to bring gout drug first marketed in Japan to the US and Europe","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}